VanEck Biotech ETF (BBH) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
VanEck Biotech ETF (BBH) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $369.1M, listed on NASDAQ, carrying a beta of 0.60 to the broader market. VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. public since 1999-11-23.
Snapshot as of May 15, 2026.
- Spot Price
- $182.24
- Total OI
- 287